Cabergoline, a Hopeful Medicine for Prolactinomas and Non-tumoral Hyperprolactinemia
Nobuhiro Miki
openalex +2 more sources
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre. [PDF]
Hamblin R+3 more
europepmc +1 more source
Prolactinoma presenting as a failed vasectomy reversal [PDF]
Adam W. Templeton+3 more
openalex +1 more source
THE RISKS OF MEDICAL TREATMENT OF PROLACTINOMA.
F. Castinetti+7 more
semanticscholar +1 more source
Impact of Tumor Size on Prolactinoma Characteristics and Treatment Outcomes: A Study of a Tunisian Cohort. [PDF]
Elleuch M+5 more
europepmc +1 more source
Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline [PDF]
Annamaria Colao+9 more
openalex +1 more source
Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas [PDF]
Gloria M. Cónsole+6 more
openalex +1 more source
Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma. [PDF]
Fox T+5 more
europepmc +1 more source
Estimating diagnostic delay in patients with pituitary adenomas in Sweden: a cross-sectional study. [PDF]
Forsgren M+13 more
europepmc +1 more source